AGC Biologics

AGC Biologics

Share

AGC Biologics has successfully manufactured more than 200 biological projects, from pre-clinical studies through commercial approvals.

We offer multiple cGMP manufacturing lines at a variety of scales for mammalian cell culture and microbial fermentation

06/08/2026

๐Ÿš€ Next stop: San Diego for BIO International 2026, June 8-11!

Connect with our senior leaders and global team on-site to explore flexible manufacturing capacity across our entire network. Whether your program requires mammalian cell culture, microbial fermentation, cell therapy, or gene therapy, we have the cGMP infrastructure to support your clinical and commercial milestones.

๐Ÿ—“๏ธ ๐’๐œ๐ก๐ž๐๐ฎ๐ฅ๐ž ๐š๐ง ๐จ๐ง-๐ฌ๐ข๐ญ๐ž ๐ฆ๐ž๐ž๐ญ๐ข๐ง๐  ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐ญ๐ž๐œ๐ก๐ง๐ข๐œ๐š๐ฅ ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ๐ฌ: https://hubs.ly/Q04klZhj0

06/04/2026

The booming demand for bispecific antibody production must be met with innovative platforms that can deliver high-quality product on shorter timelines.

๐ŸงฌAt AGC Biologics, we leverage transposase technology to improve target integration and achieve a 10-fold improvement in titers. And with automated high-throughput systems that screen thousands of clones simultaneously, we can shorten the journey to stable, productive clones.

โžก๏ธLearn more about our approach to bispecific therapy development in our blog: https://hubs.ly/Q04jnv-b0

๐Ÿ“Attending BIO International this June? Visit our team at Booth 4707 to discuss how we can support your next biologics program.

06/03/2026

Complex molecule manufacturing doesnโ€™t follow an established playbook.

Listen as Hannah Hutter, MSAT Engineer at our Seattle facility, explains how AGC Biologics combines a thorough understanding of client processes and requirements, risk mitigation, robust platforms, and process flexibility to generate high-quality biologics.

Watch the video โฌ‡๏ธ

06/02/2026

โฐ Sign up today for Outsourced Pharmaโ€™s Capabilities Update focused on Cell Therapy!

On June 16th, AGC Biologics will present our approach to advancing cell and gene therapy development and manufacturing at any stage of the pipeline. You will also learn how we identify and mitigate risk to deliver high-quality cell therapies for clinical trials or at commercial scale.

๐Ÿ‘‰๐ŸปRegister today! https://hubs.ly/Q04jnKr20

06/01/2026

๐Ÿ—“๏ธ June is ๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐จ๐ง๐ญ๐ก, a time to celebrate the advancement of immune-based cancer treatments that are reshaping cancer care.

AGC Biologics is proud to support our immunotherapy development partners by providing regulatory guidance and reliable, scalable cGMP manufacturing services for complex immunotherapies, enabling patients around the globe to access these critical treatments.

Know anyone working in immunotherapy development? Say thank you by tagging them in the comments. ๐Ÿ‘‡

Photos from AGC Biologics's post 05/28/2026

โ‡” โ€œScale-outโ€ manufacturing is a strategy every biologic developer should consider for its ability to accelerate timelines, lower costs, and derisk demand uncertainty in todayโ€™s market.

Anders Cai Holm Hansen, Principal Scientist Customer Solution Design at AGC Biologics, recently sat down for an interview with BioSpaceยฎ to discuss our single-use technology (SUT) that supports a scale-out manufacturing approach, and its ability to support high-yield perfusion processes for complex molecule manufacturing.

Read the article here: https://hubs.ly/Q04hHhJz0

05/27/2026

๐Ÿ“ฃ Cell and gene therapy webinar available on demand!

๐€ ๐Ÿ‘-๐’๐ญ๐š๐ ๐ž ๐†๐ฎ๐ข๐๐ž ๐ญ๐จ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ข๐ฏ๐ž ๐‚๐ž๐ฅ๐ฅ & ๐†๐ž๐ง๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐๐ซ๐จ๐œ๐ž๐ฌ๐ฌ ๐•๐š๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง

Watch as Monika Pema, Senior Manager MSAT, and Francesca Rossetti, Analytical Method Development Director, AGC Biologics Cell & Gene Center of Excellence in Milan, walk through best practices for advancing CGT therapies from early development to commercialization. See the strategy used by AGC Biologics to gain FDA and EMA approval of Orchard Therapeuticsโ€™ Lenmedlyโ„ข, a hematopoietic stem cell therapy for treatment of metachromatic leukodystrophy (MLD).

๐ŸŽฅ Watch now: https://hubs.ly/Q04hGPgp0

05/26/2026

Thereโ€™s an undeniable shift toward regionalizing production and supply chain in biopharma manufacturing. A new article in Pharma Boardroom explains how industry leaders, like AGC, are rising to meet this growing demand.

As our CEO, Alberto Santagostino, explains: โ€œ๐˜”๐˜ฐ๐˜ณ๐˜ฆ ๐˜ค๐˜ถ๐˜ด๐˜ต๐˜ฐ๐˜ฎ๐˜ฆ๐˜ณ๐˜ด ๐˜ข๐˜ณ๐˜ฆ ๐˜ฆ๐˜น๐˜ฑ๐˜ญ๐˜ช๐˜ค๐˜ช๐˜ต๐˜ญ๐˜บ ๐˜ณ๐˜ฆ๐˜ฒ๐˜ถ๐˜ฆ๐˜ด๐˜ต๐˜ช๐˜ฏ๐˜จ ๐˜ฅ๐˜ถ๐˜ข๐˜ญ-๐˜ณ๐˜ฆ๐˜จ๐˜ช๐˜ฐ๐˜ฏ ๐˜ด๐˜ถ๐˜ฑ๐˜ฑ๐˜ญ๐˜บ ๐˜ด๐˜ต๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜จ๐˜ช๐˜ฆ๐˜ด ๐˜ข๐˜ฏ๐˜ฅ, ๐˜ง๐˜ฐ๐˜ณ ๐˜ฏ๐˜ฐ๐˜ฏ-๐˜œ๐˜š ๐˜ฅ๐˜ฆ๐˜ฎ๐˜ข๐˜ฏ๐˜ฅ, ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ๐˜ฆ ๐˜ช๐˜ด ๐˜ฐ๐˜ง๐˜ต๐˜ฆ๐˜ฏ ๐˜ข ๐˜ค๐˜ญ๐˜ฆ๐˜ข๐˜ณ ๐˜ฆ๐˜น๐˜ฑ๐˜ฆ๐˜ค๐˜ต๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ต๐˜ฉ๐˜ข๐˜ต ๐˜ด๐˜ถ๐˜ฑ๐˜ฑ๐˜ญ๐˜บ ๐˜ด๐˜ฉ๐˜ฐ๐˜ถ๐˜ญ๐˜ฅ ๐˜ข๐˜ญ๐˜ด๐˜ฐ ๐˜ฃ๐˜ฆ ๐˜ฏ๐˜ฐ๐˜ฏ-๐˜œ๐˜š ๐˜ฃ๐˜ข๐˜ด๐˜ฆ๐˜ฅ. ๐˜š๐˜ฐ ๐˜ณ๐˜ข๐˜ต๐˜ฉ๐˜ฆ๐˜ณ ๐˜ต๐˜ฉ๐˜ข๐˜ฏ ๐˜ข ๐˜ด๐˜ช๐˜ฎ๐˜ฑ๐˜ญ๐˜ฆ ๐˜ด๐˜ฉ๐˜ช๐˜ง๐˜ต ๐˜ช๐˜ฏ ๐˜ฐ๐˜ฏ๐˜ฆ ๐˜ฅ๐˜ช๐˜ณ๐˜ฆ๐˜ค๐˜ต๐˜ช๐˜ฐ๐˜ฏ, ๐˜ธ๐˜ฆ ๐˜ด๐˜ฆ๐˜ฆ ๐˜ข ๐˜จ๐˜ฆ๐˜ฐ๐˜จ๐˜ณ๐˜ข๐˜ฑ๐˜ฉ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜ด๐˜ฑ๐˜ญ๐˜ช๐˜ฏ๐˜ต๐˜ฆ๐˜ณ๐˜ช๐˜ฏ๐˜จ ๐˜ข๐˜ญ๐˜ฐ๐˜ฏ๐˜จ ๐˜ณ๐˜ฆ๐˜จ๐˜ช๐˜ฐ๐˜ฏ๐˜ข๐˜ญ ๐˜ญ๐˜ช๐˜ฏ๐˜ฆ๐˜ด.โ€

๐Ÿ‘‰๐ŸปRead the full article for more insights from our CEO: https://hubs.ly/Q04hHl5P0

Want your business to be the top-listed Business in Bothell?
Click here to claim your Sponsored Listing.

Category

Telephone

Address


21511 23rd Drive SE
Bothell, WA
98021

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm